CCA
DGX icon

Childress Capital Advisors’s Quest Diagnostics DGX Stock Holding History

Childress Capital Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-43
Closed -$5K – 373
2020
Q4 		$5K Buy
+43
New +$5.24K ﹤0.01% 743

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Childress Capital Advisors's DGX Position: Q1 2021 in Review

Childress Capital Advisors sold out of Quest Diagnostics (DGX) in Q1 2021, closing a stake of 43 shares — an estimated $5K sold.

Childress Capital Advisors first reported a position in DGX in Q4 2020 and held it in 1 quarter. The position peaked at $5K in Q4 2020. 817 funds tracked by Wall St. Rank hold DGX as of Q1 2021.

  • Childress Capital Advisors reported no remaining Quest Diagnostics position as of Q1 2021 after selling out during the quarter.
  • Childress Capital Advisors sold 43 Quest Diagnostics shares in Q1 2021, an estimated $5K.
  • Childress Capital Advisors first reported a position in Quest Diagnostics in Q4 2020 and held it in 1 quarter.
  • Childress Capital Advisors's Quest Diagnostics position peaked at $5K in Q4 2020.
  • 817 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2021.

Based on Childress Capital Advisors's 13F filing for Q1 2021, filed 21 May 2021.